NASDAQ

DiaMedica Therapeutics Inc. (DMAC)

♥ 679 Thanks from members

Live price chart, market sentiment, and community perspectives for DiaMedica Therapeutics Inc. (NASDAQ: DMAC).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiopharmaceuticalsFounder: DiaMedica TherapeuticsLeadership: Rick Pauls (President and CEO)Holder: Adage Capital PartnersHolder: RA Capital ManagementDM199 Recombinant Protein TherapyStroke Treatment Pipeline#DMAC#DiaMedica#Biopharma#Stroke Treatment#NASDAQ